Truist Financial Corp Sells 5,018 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Truist Financial Corp lessened its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 14.1% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 30,639 shares of the health services provider’s stock after selling 5,018 shares during the period. Truist Financial Corp’s holdings in Teladoc Health were worth $6,127,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the company. First National Bank of South Miami increased its holdings in Teladoc Health by 560.0% in the 4th quarter. First National Bank of South Miami now owns 132 shares of the health services provider’s stock worth $26,000 after acquiring an additional 112 shares in the last quarter. Berman Capital Advisors LLC increased its holdings in Teladoc Health by 234.9% in the 4th quarter. Berman Capital Advisors LLC now owns 144 shares of the health services provider’s stock worth $28,000 after acquiring an additional 101 shares in the last quarter. Kathmere Capital Management LLC increased its holdings in Teladoc Health by 228.9% in the 4th quarter. Kathmere Capital Management LLC now owns 148 shares of the health services provider’s stock worth $30,000 after acquiring an additional 103 shares in the last quarter. Manchester Financial Inc. grew its holdings in Teladoc Health by 1,470.0% during the 4th quarter. Manchester Financial Inc. now owns 157 shares of the health services provider’s stock valued at $31,000 after buying an additional 147 shares in the last quarter. Finally, Corbenic Partners LLC grew its holdings in Teladoc Health by 136.4% during the 4th quarter. Corbenic Partners LLC now owns 156 shares of the health services provider’s stock valued at $31,000 after buying an additional 90 shares in the last quarter. Hedge funds and other institutional investors own 51.77% of the company’s stock.

In other Teladoc Health news, Director Glen Tullman sold 164,931 shares of Teladoc Health stock in a transaction dated Thursday, January 14th. The stock was sold at an average price of $225.12, for a total value of $37,129,266.72. Following the transaction, the director now owns 440,724 shares in the company, valued at $99,215,786.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Daniel Trencher sold 3,000 shares of Teladoc Health stock in a transaction dated Monday, January 11th. The shares were sold at an average price of $227.33, for a total value of $681,990.00. Following the completion of the transaction, the senior vice president now owns 11,413 shares in the company, valued at approximately $2,594,517.29. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 652,374 shares of company stock worth $131,871,978. Insiders own 3.42% of the company’s stock.

Shares of Teladoc Health stock opened at $178.00 on Thursday. The firm has a market cap of $27.18 billion, a P/E ratio of -124.48 and a beta of 0.30. The company has a current ratio of 6.52, a quick ratio of 6.47 and a debt-to-equity ratio of 0.43. Teladoc Health, Inc. has a 12 month low of $135.52 and a 12 month high of $308.00. The stock’s fifty day moving average price is $208.17 and its 200-day moving average price is $216.65.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, February 24th. The health services provider reported ($3.07) EPS for the quarter, missing the consensus estimate of ($0.25) by ($2.82). Teladoc Health had a negative net margin of 12.71% and a negative return on equity of 6.15%. Analysts forecast that Teladoc Health, Inc. will post -1.12 earnings per share for the current year.

A number of research analysts recently weighed in on the stock. William Blair reissued an “outperform” rating on shares of Teladoc Health in a report on Thursday, February 25th. BTIG Research raised their target price on shares of Teladoc Health from $260.00 to $330.00 and gave the company a “buy” rating in a report on Tuesday, January 26th. Piper Sandler cut their target price on shares of Teladoc Health from $305.00 to $291.00 and set an “overweight” rating for the company in a report on Wednesday, March 3rd. Craig Hallum raised their target price on shares of Teladoc Health from $200.00 to $212.00 and gave the company a “hold” rating in a report on Thursday, December 17th. Finally, SVB Leerink raised their price target on Teladoc Health from $256.00 to $266.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 3rd. Fourteen equities research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company’s stock. Teladoc Health currently has a consensus rating of “Buy” and a consensus price target of $241.38.

About Teladoc Health

Teladoc Health, Inc engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure.

Read More: LIBOR

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.